CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRSP Price/Volume Stats
| Current price | $40.53 | 52-week high | $91.10 |
| Prev. close | $40.30 | 52-week low | $36.52 |
| Day low | $40.45 | Volume | 1,387,300 |
| Day high | $41.55 | Avg. volume | 1,767,918 |
| 50-day MA | $45.65 | Dividend yield | N/A |
| 200-day MA | $51.13 | Market Cap | 3.46B |
CRSP Stock Price Chart Interactive Chart >
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
CRSP Price Returns
| 1-mo | -0.47% |
| 3-mo | -11.89% |
| 6-mo | -29.60% |
| 1-year | -37.89% |
| 3-year | -35.27% |
| 5-year | -28.35% |
| YTD | 2.97% |
| 2024 | -37.12% |
| 2023 | 54.00% |
| 2022 | -46.36% |
| 2021 | -50.51% |
| 2020 | 151.39% |
Continue Researching CRSP
Here are a few links from around the web to help you further your research on CRISPR Therapeutics AG's stock as an investment opportunity:CRISPR Therapeutics AG (CRSP) Stock Price | Nasdaq
CRISPR Therapeutics AG (CRSP) Stock Quote, History and News - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...